Why should governments invest in antibiotic drug discovery against multi-drug-resistant bacteria?

Recent Patents on Anti-Infective Drug Discovery

Volumn 9, Issue 2, 2015, Pages 150-151

  Meletis, Georgios ^a  

^a Labnet Laboratories   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; GOVERNMENT; GRAM NEGATIVE BACTERIUM; HUMAN; INVESTMENT; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 84930509467     PISSN: 1574891X     EISSN: 22124071     Source Type: Journal    
DOI: 10.2174/1574891x10666150408153232     Document Type: Article

References (1)

1. Centers for Disease Control and Prevention. Available at: Threat report 2013. http://www.cdc.gov/drugresistance/threat-report-2013(Accessed on: March 10, 2015).